Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jane J. Clarke is active.

Publication


Featured researches published by Jane J. Clarke.


Mutation Research-genetic Toxicology and Environmental Mutagenesis | 2001

Re-evaluation of the mutagenic potential of quinacrine dihydrochloride dihydrate.

Jane J. Clarke; David C. Sokal; Diane B Campen; Ramadevi Gudi; Valentine O. Wagner; Richard H.C. San; David Jacobson-Kram

Quinacrine has been used for voluntary female non-surgical sterilization for its ability to produce tubal occlusion. Safety issues regarding quinacrine have been raised because it has been shown to intercalate with DNA. Therefore, safety issues need to be resolved by appropriate toxicology studies to support a review for human transcervical use. Such toxicology studies include mutagenicity assays. Here we report an evaluation of the genotoxicity of quinacrine dihydrochloride dihydrate (QH) using a battery of assays. In the bacterial mutagenicity assay, QH was strongly positive in Salmonella typhimurium tester strain TA1537 with and without S9-activation and in S. typhimurium tester strain TA98 with S9-activation; QH was also strongly positive in Escherichia coli WP2 uvrA without S9-activation. QH was not mutagenic in S. typhimurium tester strains TA100 and TA1535 with and without S9-activation. QH was mutagenic in the mouse lymphoma assay in the absence of S9-activation. QH was clastogenic in Chinese hamster ovary (CHO) cells, with and without S9-activation. QH was negative for polyploidy in the same chromosome aberration test. Using a triple intraperitoneal injection treatment protocol in both male and female mice, QH was negative in the in vivo mouse micronucleated erythrocyte (micronucleus) assay. These results confirm that QH is mutagenic and clastogenic in vitro and suggest a potential risk to human health due to QH exposure after intrauterine exposure.


Food and Chemical Toxicology | 2008

Evaluation of the butter flavoring chemical diacetyl and a fluorochemical paper additive for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells

Paul Whittaker; Jane J. Clarke; Richard H.C. San; Timothy H. Begley; Virginia C. Dunkel

Diacetyl (2,3-butanedione) is a yellowish liquid that is usually mixed with other ingredients to produce butter flavor or other flavors in a variety of food products. Inhalation of butter flavoring vapors was first associated with clinical bronchiolitis obliterans among workers in microwave popcorn production. Recent findings have shown irreversible obstructive lung disease among workers not only in the microwave popcorn industry, but also in flavoring manufacture, and in chemical synthesis of diacetyl, a predominant chemical for butter flavoring. It has been reported that perfluorochemicals utilized in food packaging are migrating into foods and may be sources of oral exposure. Relatively small quantities of perfluorochemicals are used in the manufacturing of paper or paperboard that is in direct contact with food to repel oil or grease and water. Because of recent concerns about perfluorochemicals such as those found on microwave popcorn bags (e.g. Lodyne P208E) and diacetyl in foods, we evaluated both compounds for mutagenicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells. Lodyne P208E was less toxic than diacetyl and did not induce a mutagenic response. Diacetyl induced a highly mutagenic response in the L5178Y mouse lymphoma mutation assay in the presence of human liver S9 for activation. The increase in the frequency of small colonies in the assay with diacetyl indicates that diacetyl causes damage to multiple loci on chromosome 11 in addition to functional loss of the thymidine kinase locus.


Environmental and Molecular Mutagenesis | 2012

Summary of in vitro genetic toxicology assay results: Expected and unexpected effects of recent study design modifications

Jane J. Clarke; Timothy Lawlor; Wannie Madraymootoo; Kamala Pant; Robert R. Young; Valentine O. Wagner; Marilyn J. Aardema

Key modifications to in vitro genetic toxicology testing have been made in the last 5 years including the use of optimization approaches such as structure–activity relationships and screening assays to identify and eliminate potentially genotoxic chemicals from further consideration, better guidance on cytotoxicity assessment and dose selection, and greater use of p53‐competent human cells. To determine the effect of these changes on testing outcomes, the pattern of positive results across assays conducted by BioReliance from 2005 to 2010 was examined. Data were tabulated for good laboratory practice (GLP)‐compliant Ames, mouse lymphoma (MLA), chromosome aberration in Chinese hamster ovary (CHO) cells, and in human peripheral blood lymphocytes (HPBL) assays along with non‐GLP screening Ames assays. A decrease in percentage of positive results in MLA and CHO chromosome aberration assays was observed, whereas the percentage of positive Ames assays remained consistent. This was not unexpected because MLA and CHO cytogenetic assays have undergone the most substantive changes (e.g., the establishment of the Global Evaluation Factor for the MLA and the use of the relative increase in cell counts in CHO chromosome aberration assays). Over the last 5 years, there has been an increase in the percentage of positive results observed in the chromosome aberration assay in HPBL. It is speculated that this may have led to an increase in HPBL‐positive results if the chemicals routed to HPBL had previous positive genotoxicity results. Another factor may be the lack of a reliable cytotoxicity measurement in the HPBL assay. Environ. Mol. Mutagen., 2012.


Environmental and Molecular Mutagenesis | 2006

Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up meeting of the international workshop on Genotoxicity testing—Aberdeen, Scotland, 2003—Assay acceptance criteria, positive controls, and data evaluation

Martha M. Moore; Masamitsu Honma; Julie Clements; George Bolcsfoldi; Brian Burlinson; Maria Cifone; Jane J. Clarke; Robert R. Delongchamp; Robert Durward; Michael D. Fellows; B. Bhaskar Gollapudi; Saimei Hou; Peter Jenkinson; Melvin Lloyd; Jenness B. Majeska; Brian Myhr; Michael R. O'Donovan; Takashi Omori; Colin Riach; Richard H.C. San; Leon F. Stankowski; Ajit K. Thakur; Freddy Van Goethem; Shinobu Wakuri; Isao Yoshimura


Mutation Research-genetic Toxicology and Environmental Mutagenesis | 2005

Lack of mutagenicity of chromium picolinate in the hypoxanthine phosphoribosyltransferase gene mutation assay in Chinese hamster ovary cells.

Ronald S. Slesinski; Jane J. Clarke; Richard H.C. San; Ramadevi Gudi


Food and Chemical Toxicology | 2005

Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells.

Paul Whittaker; Richard H.C. San; Jane J. Clarke; Harold E. Seifried; Virginia C. Dunkel


Mutation Research-genetic Toxicology and Environmental Mutagenesis | 2007

Mouse lymphoma thymidine kinase gene mutation assay: Meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment

Martha M. Moore; Masamitsu Honma; Julie Clements; George Bolcsfoldi; Brian Burlinson; Maria Cifone; Jane J. Clarke; Philip Clay; Rupa S. Doppalapudi; Michael D. Fellows; B. Bhaskar Gollapudi; Saimei Hou; Peter Jenkinson; Wolfgang Muster; Kamala Pant; Darren Kidd; Elisabeth Lorge; Melvyn Lloyd; Brian Myhr; Michael R. O’Donovan; Colin Riach; Leon F. Stankowski; Ajit K. Thakur; Freddy Van Goethem


Mutation Research-genetic Toxicology and Environmental Mutagenesis | 2005

Chromium picolinate does not produce chromosome damage in CHO cells.

Ramadevi Gudi; Ronald S. Slesinski; Jane J. Clarke; Richard H.C. San


Environmental and Molecular Mutagenesis | 2001

Genotoxicity of iron chelators in L5178Y mouse lymphoma cells

Paul Whittaker; Harold E. Seifried; Richard H.C. San; Jane J. Clarke; Virginia C. Dunkel


Food and Chemical Toxicology | 2008

Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells

Paul Whittaker; Jane J. Clarke; Richard H.C. San; Joseph M. Betz; Harold E. Seifried; Lowri S. De Jager; Virginia C. Dunkel

Collaboration


Dive into the Jane J. Clarke's collaboration.

Top Co-Authors

Avatar

Paul Whittaker

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Virginia C. Dunkel

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Harold E. Seifried

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ramadevi Gudi

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Colin Riach

Charles River Laboratories

View shared research outputs
Top Co-Authors

Avatar

Joseph M. Betz

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge